Kurve Therapeutics
Bypassing the Blood-Brain Barrier
Analytics
Rialto Markets
08/03/2022
08/03/2023
$580
$50,000,000
$580
Equity - Common
RegA+
$5.80
Lynnwood, Washington
Healthcare & Pharmaceuticals
HealthTech
Balance Sheet
Cash and Cash Equivalents |
$373,804 |
Accounts and Notes Receivable |
$15,000 |
Total Assets |
$640,574 |
Accounts Payable & Accrued Liabilities |
$28,331 |
Long Term Debt |
$507,500 |
Total Liabilities |
$606,726 |
Total Stockholders' Equity |
$33,848 |
Total Liabilities and Equity |
$640,574 |
Statement of Comprehensive Income Information
Total Revenues |
$70,700 |
Costs & Expenses Applicable to Rev |
$128,344 |
Net Income |
$-65,427 |
Earnings Per Share - Basic |
$0.00 |
Earnings Per Share - Diluted |
$0.00 |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual